IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (5 Suppl 14), 18-30
- https://doi.org/10.1053/sonc.2002.35644